Dyslipidaemia Panel (includes Familial Hypercholesterolaemia)

Overview

Test Name

Dyslipidaemia Panel (includes Familial Hypercholesterolaemia)

Test Code

CAE1009

Test Category

Gene Panels

Test Subcategory

Cardiology

Disease(s) Targeted

Dyslipidaemia (includes Familial Hypercholesterolaemia)

Who Is The Test For?

Patients with a family history, clinical suspicion, or diagnosis of Dyslipidaemia (including Familial Hypercholesterolaemia)

Test Approach

Whole exome sequencing (WES) with in silico gene panel analysis

No. Of Genes

Panel Content

ABCA1, ABCG5, ABCG8, ALMS1, APOA1, APOA5, APOB, APOC2, APOC3, APOE, CREB3L3, CYP27A1, GPD1, GPIHBP1, LDLR, LDLRAP1, LIPA, LMF1, LPL, PCSK9

Mitochondrial Genome Included In The Analysis

Deliverables

Clinical Report (Download a sample report here)

Turnaround Time

~3-6 weeks*

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Dyslipidaemia

Dyslipidaemia refers to an abnormal level of lipids (fats) in the blood, including cholesterol and triglycerides.

It is a key risk factor for cardiovascular diseases (CVD), such as coronary artery disease (CAD), stroke, and peripheral artery disease (PAD).